Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Kissei Pharmaceutical Co ( (JP:4547) ).
Kissei Pharmaceutical Co. announced an increase in its year-end dividend to ¥55 per share, reflecting a ¥10 rise from the previous forecast, resulting in an annual dividend of ¥100 per share. This decision is part of the company’s new mid-term management plan, ‘Beyond 80,’ which emphasizes shareholder returns, including a planned allocation of 57 billion yen for dividends and share buybacks over the next five years.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and has been working on transitioning from a patent cliff to a growth phase.
Average Trading Volume: 72,057
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen160.2B
For detailed information about 4547 stock, go to TipRanks’ Stock Analysis page.